COLMERS CAPITAL LTD

Company number 14802577 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

COLMERS CAPITAL LTD - Analysis Report

Company Number: 14802577

Analysis Date: 2025-07-29 14:44 UTC

Financial Health Assessment for COLMERS CAPITAL LTD (As at 30 June 2024)


1. Financial Health Score: Grade C

Explanation:
This score reflects a company in its early stage with significant financial leverage and net liabilities, indicating some financial strain but with potential support from directors. The company shows symptoms of distress (net liabilities and working capital deficit) but also has valuable investments and director backing that could underpin future stability if managed prudently.


2. Key Vital Signs

Metric Value Interpretation
Net Assets (Equity) -£75,471 Negative equity indicates financial strain; liabilities exceed assets.
Fixed Assets (Investments) £4,609,250 Strong asset base in investments, a vital lifeline.
Current Assets (Cash) £50,580 Very low cash reserves; limited liquidity "blood supply".
Current Liabilities £3,467,810 High short-term debts; "immediate obligations" pressure.
Net Current Assets -£3,417,230 Negative working capital; unable to cover short-term debts from current assets.
Long-term Liabilities £1,267,491 Substantial longer-term debt secured on assets.
Shareholders’ Funds -£75,471 Deficit reflects accumulated losses or undercapitalization.
Directors’ Loans Significant loans supporting the company, indicating reliance on insider funding.

3. Diagnosis

Symptoms Analysis:

  • The company is in its infancy (incorporated April 2023), so it is common to see initial financial strain as business operations and investments ramp up.
  • The net liability position (-£75k equity) is a symptom of early-stage investment and/or losses, implying the company has spent more than it has earned or funded to date.
  • The large fixed asset investment (£4.6m) suggests strategic acquisitions or investments, potentially related to subsidiaries or holding company activities. These assets are the company's "organ systems," crucial for long-term vitality.
  • Working capital deficit (-£3.4m) is a warning sign that short-term debts cannot be met by current liquid assets, akin to "poor short-term blood flow," which can threaten operational health if not managed carefully.
  • The company relies heavily on director loans and group funding (£2.08m owed to group, plus director loans), indicating it currently depends on insider financing to stay afloat — a sign both of support and vulnerability if that funding were withdrawn.
  • The directors have assessed the going concern basis positively, expecting continued support and ability to meet debts for at least 12 months, which is reassuring but hinges on continued insider backing.

Overall Diagnosis:
The financial health shows early-stage stress with heavy leverage, but offset by valuable investments and committed directors. The company is more "fragile" than "robust" but not yet critically ill. The financial structure shows symptoms of imbalance that require careful monitoring and proactive management.


4. Recommendations

To improve financial wellness and strengthen the company’s financial health, consider the following actions:

  1. Improve Liquidity:

    • Increase cash reserves through additional equity funding or operational cash inflows to reduce working capital deficit.
    • Negotiate longer payment terms with creditors to ease short-term liquidity pressure.
  2. Debt Management:

    • Explore refinancing options to reduce short-term liabilities or convert some current liabilities to longer-term debt to improve liquidity ratios.
    • Engage with lenders and group companies to formalize and possibly restructure director loans to provide stable funding.
  3. Operational Cash Flow Enhancement:

    • Accelerate revenue-generating activities or monetization of investments to generate healthy cash flow — the company’s "heartbeat."
    • Control operating costs tightly to manage cash burn until the company reaches break-even.
  4. Financial Monitoring & Reporting:

    • Implement frequent financial reviews and cash flow forecasting to detect "symptoms" of distress early.
    • Consider engaging financial advisors to assist with budgeting, forecasting, and scenario planning.
  5. Governance and Transparency:

    • Maintain clear communication with shareholders and creditors about the company’s strategy and financial status.
    • Ensure compliance with filing deadlines and statutory requirements to avoid penalties and reputational risk.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.